Abstract
Rapid progress in next generation sequencing technologies provided deeper insights into the mechanism underlying disease pathology. It has broadened our horizon to understand the cellular processes at individual cell level. Single-cell analysis allowed uncovering new dimensions that could track the trajectories of distant cell lineage in tumor development. In recent years, the popularity of single-cell omics gained utmost momentum. Our review focuses on the use of single-cell omics in cellular model of cancer and its clinical application. It also highlights the potential of using multiomics approach to understand the cellular heterogeneity at multiple layers. The data generated using single-cell multiomics revealed the key biological processes, mechanism of cellular heterogeneity, and resistance mechanism. The knowledge captured from the single-cell analysis facilitated a wider understanding of disease and in developing efficient treatment strategies.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Ren X, Kang B, Zhang Z (2018) Understanding tumor ecosystems by single-cell sequencing: promises and limitations. Genome Biol 19(1):211
Chen F et al (2015) New horizons in tumor microenvironment biology: challenges and opportunities. BMC Med 13:45
Yuan Y et al (2016) Role of the tumor microenvironment in tumor progression and the clinical applications (Review). Oncol Rep 35(5):2499–2515
Guan J, Chen J (2013) Mesenchymal stem cells in the tumor microenvironment. Biomed Rep 1(4):517–521
Kamdje AHN et al (2017) Mesenchymal stromal cells’ role in tumor microenvironment: involvement of signaling pathways. Cancer Biol Med 14(2):129–141
Arena S et al (2018) Characterization of tumor-derived mesenchymal stem cells potentially differentiating into cancer-associated fibroblasts in lung cancer. Clin Transl Oncol 20(12):1582–1591
Ishihara S, Ponik SM, Haga H (2017) Mesenchymal stem cells in breast cancer: response to chemical and mechanical stimuli. Oncoscience 4(11–12):158–159
Fouad YA, Aanei C (2017) Revisiting the hallmarks of cancer. Am J Cancer Res 7(5):1016–1036
Hanahan D, Weinberg RA (2011) Hallmarks of cancer: the next generation. Cell 144(5):646–674
Wang M et al (2017) Role of tumor microenvironment in tumorigenesis. J Cancer 8(5):761–773
Thunnissen E, van der Oord K, den Bakker M (2014) Prognostic and predictive biomarkers in lung cancer. A review. Virchows Arch 464(3):347–358
McNamara MG, Sahebjam S (2013) Mason WP (2013) Emerging biomarkers in glioblastoma. Cancers (Basel) 5(3):1103–11019
Henry NL, Hayes DF (2012) Cancer biomarkers. Mol Oncol 6(2):140–146
Roma-Rodrigues C et al (2019) Targeting tumor microenvironment for cancer therapy. Int J Mol Sci 20(4):840
Kim J, Bae JS (2016) Tumor-associated macrophages and neutrophils in tumor microenvironment. Mediat Inflamm 2016:6058147
Quail DF, Joyce JA (2013) Microenvironmental regulation of tumor progression and metastasis. Nat Med 19(11):1423–1437
Hida K et al (2018) Contribution of tumor endothelial cells in cancer progression. Int J Mol Sci 19(5):1272
Maishi N, Hida K (2017) Tumor endothelial cells accelerate tumor metastasis. Cancer Sci 108(10):1921–1926
Onimaru M, Yonemitsu Y (2011) Angiogenic and lymphangiogenic cascades in the tumor microenvironment. Front Biosci (Schol Ed) 3:216–225
Hui L, Chen Y (2015) Tumor microenvironment: sanctuary of the devil. Cancer Lett 368(1):7–13
Wu T, Dai Y (2017) Tumor microenvironment and therapeutic response. Cancer Lett 387:61–68
Walker C, Mojares E, Del Rio Hernandez A (2018) Role of extracellular matrix in development and cancer progression. Int J Mol Sci 19(10):3028
Sokolenko AP, Imyanitov EN (2018) Molecular diagnostics in clinical oncology. Front Mol Biosci 5:76
Ryu D et al (2016) Deciphering intratumor heterogeneity using cancer genome analysis. Hum Genet 135(6):635–642
Wei Q et al (2017) Multiregion whole-exome sequencing of matched primary and metastatic tumors revealed genomic heterogeneity and suggested polyclonal seeding in colorectal cancer metastasis. Ann Oncol 28(9):2135–2141
Varon-Gonzalez C, Navarro N (2019) Epistasis regulates the developmental stability of the mouse craniofacial shape. Heredity (Edinb) 122(5):501–512
Racle J et al (2017) Simultaneous enumeration of cancer and immune cell types from bulk tumor gene expression data. Elife 6:e26476
Lo PK, Zhou Q (2018) Emerging techniques in single-cell epigenomics and their applications to cancer research. J Clin Genom 1(1)
Bartoschek M et al (2018) Spatially and functionally distinct subclasses of breast cancer-associated fibroblasts revealed by single cell RNA sequencing. Nat Commun 9(1):5150
Li H et al (2018) Author correction: reference component analysis of single-cell transcriptomes elucidates cellular heterogeneity in human colorectal tumors. Nat Genet 50(12):1754
Muller S et al (2017) Single-cell profiling of human gliomas reveals macrophage ontogeny as a basis for regional differences in macrophage activation in the tumor microenvironment. Genome Biol 18(1):234
Valdes-Mora F et al (2018) Single-cell transcriptomics in cancer immunobiology: the future of precision oncology. Front Immunol 9:2582
Navin N et al (2011) Tumour evolution inferred by single-cell sequencing. Nature 472(7341):90–94
Wang Y et al (2014) Clonal evolution in breast cancer revealed by single nucleus genome sequencing. Nature 512(7513):155–160
Francis JM et al (2014) EGFR variant heterogeneity in glioblastoma resolved through single-nucleus sequencing. Cancer Discov 4(8):956–971
Xu X et al (2012) Single-cell exome sequencing reveals single-nucleotide mutation characteristics of a kidney tumor. Cell 148(5):886–895
Yu C et al (2014) Discovery of biclonal origin and a novel oncogene SLC12A5 in colon cancer by single-cell sequencing. Cell Res 24(6):701–712
Wu H et al (2017) Evolution and heterogeneity of non-hereditary colorectal cancer revealed by single-cell exome sequencing. Oncogene 36(20):2857–2867
Li Y et al (2012) Single-cell sequencing analysis characterizes common and cell-lineage-specific mutations in a muscle-invasive bladder cancer. Gigascience 1(1):12
Gawad C, Koh W, Quake SR (2014) Dissecting the clonal origins of childhood acute lymphoblastic leukemia by single-cell genomics. Proc Natl Acad Sci USA 111(50):17947–17952
Li C et al (2017) Single-cell exome sequencing identifies mutations in KCP, LOC440040, and LOC440563 as drivers in renal cell carcinoma stem cells. Cell Res 27(4):590–593
Yang Z et al (2017) Single-cell sequencing reveals variants in ARID1A, GPRC5A and MLL2 driving self-renewal of human bladder cancer stem cells. Eur Urol 71(1):8–12
Caswell DR, Swanton C (2017) The role of tumour heterogeneity and clonal cooperativity in metastasis, immune evasion and clinical outcome. BMC Med 15(1):133
Leung ML et al (2017) Single-cell DNA sequencing reveals a late-dissemination model in metastatic colorectal cancer. Genome Res 27(8):1287–1299
Eirew P et al (2015) Dynamics of genomic clones in breast cancer patient xenografts at single-cell resolution. Nature 518(7539):422–426
Baxter E et al (2014) Epigenetic regulation in cancer progression. Cell Biosci 4:45
Chatterjee A, Rodger EJ, Eccles MR (2018) Epigenetic drivers of tumourigenesis and cancer metastasis. Semin Cancer Biol 51:149–159
Xi Y et al (2018) Histone modification profiling in breast cancer cell lines highlights commonalities and differences among subtypes. BMC Genom 19(1):150
Li LC, Carroll PR, Dahiya R (2005) Epigenetic changes in prostate cancer: implication for diagnosis and treatment. J Natl Cancer Inst 97(2):103–115
Kanwal R, Gupta S (2010) Epigenetics and cancer. J Appl Physiol 109(2):598–605
Litzenburger UM et al (2017) Single-cell epigenomic variability reveals functional cancer heterogeneity. Genome Biol 18(1):15
Guo H et al (2013) Single-cell methylome landscapes of mouse embryonic stem cells and early embryos analyzed using reduced representation bisulfite sequencing. Genome Res 23(12):2126–2135
Gaiti F et al (2019) Epigenetic evolution and lineage histories of chronic lymphocytic leukaemia. Nature 569(7757):576–580
Farlik M et al (2015) Single-cell DNA methylome sequencing and bioinformatic inference of epigenomic cell-state dynamics. Cell Rep 10(8):1386–1397
Buenrostro JD et al (2015) Single-cell chromatin accessibility reveals principles of regulatory variation. Nature 523(7561):486–490
Patel AP et al (2014) Single-cell RNA-seq highlights intratumoral heterogeneity in primary glioblastoma. Science 344(6190):1396–1401
Tirosh I et al (2016) Dissecting the multicellular ecosystem of metastatic melanoma by single-cell RNA-seq. Science 352(6282):189–196
Giustacchini A et al (2017) Single-cell transcriptomics uncovers distinct molecular signatures of stem cells in chronic myeloid leukemia. Nat Med 23(6):692–702
Lawson DA et al (2015) Single-cell analysis reveals a stem-cell program in human metastatic breast cancer cells. Nature 526(7571):131–135
Liu Y, Cao X (2016) Immunosuppressive cells in tumor immune escape and metastasis. J Mol Med (Berl) 94(5):509–522
Zheng C et al (2017) Landscape of infiltrating T cells in liver cancer revealed by single-cell sequencing. Cell 169(7):1342–1356
Chung W et al (2017) Single-cell RNA-seq enables comprehensive tumour and immune cell profiling in primary breast cancer. Nat Commun 8:15081
Roth A et al (2014) PyClone: statistical inference of clonal population structure in cancer. Nat Methods 11(4):396–398
Miller CA et al (2014) SciClone: inferring clonal architecture and tracking the spatial and temporal patterns of tumor evolution. PLoS Comput Biol 10(8):e1003665
Zou M, Jin R, Au KF (2018) Revealing tumor heterogeneity of breast cancer by utilizing the linkage between somatic and germline mutations. Brief Bioinform
Zhang J et al (2014) Intratumor heterogeneity in localized lung adenocarcinomas delineated by multiregion sequencing. Science 346(6206):256–259
Zhang LL et al (2017) Multiregion sequencing reveals the intratumor heterogeneity of driver mutations in TP53-driven non-small cell lung cancer. Int J Cancer 140(1):103–108
Ledgerwood LG et al (2016) The degree of intratumor mutational heterogeneity varies by primary tumor sub-site. Oncotarget 7(19):27185–27198
Yan T et al (2019) Multi-region sequencing unveils novel actionable targets and spatial heterogeneity in esophageal squamous cell carcinoma. Nat Commun 10(1):1670
Hao JJ et al (2016) Spatial intratumoral heterogeneity and temporal clonal evolution in esophageal squamous cell carcinoma. Nat Genet 48(12):1500–1507
Kim TM et al (2015) Subclonal genomic architectures of primary and metastatic colorectal cancer based on intratumoral genetic heterogeneity. Clin Cancer Res 21(19):4461–4472
Ahmed M, Li LC (2013) Adaptation and clonal selection models of castration-resistant prostate cancer: current perspective. Int J Urol 20(4):362–371
Horning AM et al (2018) Single-cell RNA-seq reveals a subpopulation of prostate cancer cells with enhanced cell-cycle-related transcription and attenuated androgen response. Cancer Res 78(4):853–864
Casasent AK, Edgerton M, Navin NE (2017) Genome evolution in ductal carcinoma in situ: invasion of the clones. J Pathol 241(2):208–218
Casasent AK et al (2018) Multiclonal invasion in breast tumors identified by topographic single cell sequencing. Cell 172(1–2):205–217
Sottoriva A et al (2015) A big bang model of human colorectal tumor growth. Nat Genet 47(3):209–216
Sarkar S et al (2013) Cancer development, progression, and therapy: an epigenetic overview. Int J Mol Sci 14(10):21087–21113
Byler S et al (2014) Genetic and epigenetic aspects of breast cancer progression and therapy. Anticancer Res 34(3):1071–1077
Byler S, Sarkar S (2014) Do epigenetic drug treatments hold the key to killing cancer progenitor cells? Epigenomics 6(2):161–165
Campbell PJ et al (2010) The patterns and dynamics of genomic instability in metastatic pancreatic cancer. Nature 467(7319):1109–1113
Sosa Iglesias V et al (2018) Drug resistance in non-small cell lung cancer: a potential for NOTCH targeting? Front Oncol 8:267
Lopez-Verdin S et al (2018) Molecular markers of anticancer drug resistance in head and neck squamous cell carcinoma: a literature review. Cancers (Basel) 10(10):376
Ansell A et al (2016) Epidermal growth factor is a potential biomarker for poor cetuximab response in tongue cancer cells. J Oral Pathol Med 45(1):9–16
Sauna ZE, Ambudkar SV (2001) Characterization of the catalytic cycle of ATP hydrolysis by human P-glycoprotein. The two ATP hydrolysis events in a single catalytic cycle are kinetically similar but affect different functional outcomes. J Biol Chem 276(15):11653–11661
Hilgendorf C et al (2007) Expression of thirty-six drug transporter genes in human intestine, liver, kidney, and organotypic cell lines. Drug Metab Dispos 35(8):1333–1340
Haber M et al (2006) Association of high-level MRP1 expression with poor clinical outcome in a large prospective study of primary neuroblastoma. J Clin Oncol 24(10):1546–1553
Friedrich RE, Punke C, Reymann A (2004) Expression of multi-drug resistance genes (mdr1, mrp1, bcrp) in primary oral squamous cell carcinoma. Vivo 18(2):133–147
Rivlin N et al (2011) Mutations in the p53 Tumor Suppressor Gene: Important Milestones at the Various Steps of Tumorigenesis. Genes Cancer 2(4):466–474
Holohan C et al (2013) Cancer drug resistance: an evolving paradigm. Nat Rev Cancer 13(10):714–726
Kobayashi S et al (2005) EGFR mutation and resistance of non-small-cell lung cancer to gefitinib. N Engl J Med 352(8):786–792
Razis E et al (2011) Evaluation of the association of PIK3CA mutations and PTEN loss with efficacy of trastuzumab therapy in metastatic breast cancer. Breast Cancer Res Treat 128(2):447–456
Cook KL et al (2014) Hydroxychloroquine inhibits autophagy to potentiate antiestrogen responsiveness in ER+breast cancer. Clin Cancer Res 20(12):3222–3232
Curtin NJ (2012) DNA repair dysregulation from cancer driver to therapeutic target. Nat Rev Cancer 12(12):801–817
Nogueira GAS et al (2018) Polymorphisms in DNA mismatch repair pathway genes predict toxicity and response to cisplatin chemoradiation in head and neck squamous cell carcinoma patients. Oncotarget 9(51):29538–29547
Chae YK et al (2018) Epithelial-mesenchymal transition (EMT) signature is inversely associated with T-cell infiltration in non-small cell lung cancer (NSCLC). Sci Rep 8(1):2918
Bearzatto A et al (2000) Epigenetic regulation of the MGMT and hMSH6 DNA repair genes in cells resistant to methylating agents. Cancer Res 60(12):3262–3270
Navin N et al (2010) Inferring tumor progression from genomic heterogeneity. Genome Res 20(1):68–80
McGranahan N, Swanton C (2017) Clonal Heterogeneity and Tumor Evolution: Past, Present, and the Future. Cell 168(4):613–628
Van Allen EM et al (2015) Genomic correlates of response to CTLA-4 blockade in metastatic melanoma. Science 350(6257):207–211
Rizvi NA et al (2015) Cancer immunology. Mutational landscape determines sensitivity to PD-1 blockade in non-small cell lung cancer. Science 348(6230):124–128
Fares CM et al (2019) Mechanisms of resistance to immune checkpoint blockade: why does checkpoint inhibitor immunotherapy not work for all patients? Am Soc Clin Oncol Educ Book 39:147–164
Tang F et al (2009) mRNA-Seq whole-transcriptome analysis of a single cell. Nat Methods 6(5):377–382
Zheng GX et al (2016) Haplotyping germline and cancer genomes with high-throughput linked-read sequencing. Nat Biotechnol 34(3):303–311
Gierahn TM et al (2017) Seq-Well: portable, low-cost RNA sequencing of single cells at high throughput. Nat Methods 14(4):395–398
Wang Y, Navin NE (2015) Advances and applications of single-cell sequencing technologies. Mol Cell 58(4):598–609
Hou Y et al (2016) Single-cell triple omics sequencing reveals genetic, epigenetic, and transcriptomic heterogeneity in hepatocellular carcinomas. Cell Res 26(3):304–319
Lambrechts D et al (2018) Phenotype molding of stromal cells in the lung tumor microenvironment. Nat Med 24(8):1277–1289
Ma KY et al (2019) Single-cell RNA sequencing of lung adenocarcinoma reveals heterogeneity of immune response-related genes. JCI Insight 4(4):e121387
Pantel K, Speicher MR (2016) The biology of circulating tumor cells. Oncogene 35(10):1216–1224
Zhu Z et al (2018) Progress and challenges of sequencing and analyzing circulating tumor cells. Cell Biol Toxicol 34(5):405–415
Yadavalli S et al (2017) Data-driven discovery of extravasation pathway in circulating tumor cells. Sci Rep 7:43710
Krebs MG et al (2014) Molecular analysis of circulating tumour cells-biology and biomarkers. Nat Rev Clin Oncol 11(3):129–144
Arya SK, Lim B, Rahman AR (2013) Enrichment, detection and clinical significance of circulating tumor cells. Lab Chip 13(11):1995–2027
Khoo BL et al (2015) Short-term expansion of breast circulating cancer cells predicts response to anti-cancer therapy. Oncotarget 6(17):15578–15593
Cristofanilli M et al (2004) Circulating tumor cells, disease progression, and survival in metastatic breast cancer. N Engl J Med 351(8):781–791
Balakrishnan A et al (2019) Circulating Tumor Cell cluster phenotype allows monitoring response to treatment and predicts survival. Sci Rep 9(1):7933
Lianidou ES, Markou A, Strati A (2015) The role of CTCs as tumor biomarkers. Adv Exp Med Biol 867:341–367
Shaw JA et al (2017) Mutation analysis of cell-free DNA and single circulating tumor cells in metastatic breast cancer patients with high circulating tumor cell counts. Clin Cancer Res 23(1):88–96
De Luca F et al (2016) Mutational analysis of single circulating tumor cells by next generation sequencing in metastatic breast cancer. Oncotarget 7(18):26107–26119
Gao Y et al (2017) Single-cell sequencing deciphers a convergent evolution of copy number alterations from primary to circulating tumor cells. Genome Res 27(8):1312–1322
Ni X et al (2013) Reproducible copy number variation patterns among single circulating tumor cells of lung cancer patients. Proc Natl Acad Sci USA 110(52):21083–21088
Carter L et al (2017) Molecular analysis of circulating tumor cells identifies distinct copy-number profiles in patients with chemosensitive and chemorefractory small-cell lung cancer. Nat Med 23(1):114–119
Yu M et al (2013) Circulating breast tumor cells exhibit dynamic changes in epithelial and mesenchymal composition. Science 339(6119):580–584
Ting DT et al (2014) Single-cell RNA sequencing identifies extracellular matrix gene expression by pancreatic circulating tumor cells. Cell Rep 8(6):1905–1918
Miyamoto DT et al (2015) RNA-Seq of single prostate CTCs implicates noncanonical Wnt signaling in antiandrogen resistance. Science 349(6254):1351–1356
Grillet F et al (2017) Circulating tumour cells from patients with colorectal cancer have cancer stem cell hallmarks in ex vivo culture. Gut 66(10):1802–1810
Baslan T et al (2012) Genome-wide copy number analysis of single cells. Nat Protoc 7(6):1024–1041
Leung ML et al (2015) SNES: single nucleus exome sequencing. Genome Biol 16:55
Gao R et al (2017) Nanogrid single-nucleus RNA sequencing reveals phenotypic diversity in breast cancer. Nat Commun 8(1):228
Macosko EZ et al (2015) Highly parallel genome-wide expression profiling of individual cells using nanoliter droplets. Cell 161(5):1202–1214
Grindberg RV et al (2013) RNA-sequencing from single nuclei. Proc Natl Acad Sci USA 110(49):19802–19807
Shapiro E, Biezuner T, Linnarsson S (2013) Single-cell sequencing-based technologies will revolutionize whole-organism science. Nat Rev Genet 14(9):618–630
Bernard V et al (2019) Single-cell transcriptomics of pancreatic cancer precursors demonstrates epithelial and microenvironmental heterogeneity as an early event in neoplastic progression. Clin Cancer Res 25(7):2194–2205
Kim C et al (2018) Chemoresistance evolution in triple-negative breast cancer delineated by single-cell sequencing. Cell 173(4):879–893
Azizi E et al (2018) Single-cell map of diverse immune phenotypes in the breast tumor microenvironment. Cell 174(5):1293–1308
Liu M et al (2017) Multi-region and single-cell sequencing reveal variable genomic heterogeneity in rectal cancer. BMC Cancer 17(1):787
Lavin Y et al (2017) Innate immune landscape in early lung adenocarcinoma by paired single-cell analyses. Cell 169(4):750–765
Dey SS et al (2015) Integrated genome and transcriptome sequencing of the same cell. Nat Biotechnol 33(3):285–289
Wu L et al (2015) Full-length single-cell RNA-seq applied to a viral human cancer: applications to HPV expression and splicing analysis in HeLa S3 cells. Gigascience 4:51
Dago AE et al (2014) Rapid phenotypic and genomic change in response to therapeutic pressure in prostate cancer inferred by high content analysis of single circulating tumor cells. PLoS ONE 9(8):e101777
Zhao L et al (2013) High-purity prostate circulating tumor cell isolation by a polymer nanofiber-embedded microchip for whole exome sequencing. Adv Mater 25(21):2897–2902
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2020 Springer Nature Singapore Pte Ltd.
About this chapter
Cite this chapter
Sambath, J., Patel, K., Limaye, S., Kumar, P. (2020). Single-Cell Multiomics: Dissecting Cancer. In: Srinivasa, K., Siddesh, G., Manisekhar, S. (eds) Statistical Modelling and Machine Learning Principles for Bioinformatics Techniques, Tools, and Applications. Algorithms for Intelligent Systems. Springer, Singapore. https://doi.org/10.1007/978-981-15-2445-5_14
Download citation
DOI: https://doi.org/10.1007/978-981-15-2445-5_14
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-15-2444-8
Online ISBN: 978-981-15-2445-5
eBook Packages: Intelligent Technologies and RoboticsIntelligent Technologies and Robotics (R0)